PROGRAMME
Kindly note that the programme will still be subject to changes.
Thursday, October 22, 2026
Room 1
08:00-09:00
AI in cardiovascular imaging: The time is now?! (All Levels)
Strengths and challenges of AI in imaging
TBA
AI in cardiac CT: Current role, future outlook
K. Nikolaou, Tuebingen/DE
AI in cardiac MRI: Current role, future outlook
TBA
Q&A
09:00-09:05 Break
09:05-10:05
ESCR meets NASCI: Aorta imaging and beyond (All Levels)
ESCR aortic imaging practice recommendations
N. Galea, Rome/IT
Non-invasive imaging in peripheral arterial occlusive disease
TBA
How does PCCT change vascular imaging?
TBA
Q&A
10:05-10:20 Industry Pitch Session
10:20-10:50 Break
10:50-11:00
Opening Ceremony
Introduction & Welcome to Rotterdam
R. Vliegenthart, Rotterdam/NL
11:00-12:00
Opening Session: Connect to Impact
ESCR: Connecting cardiovascular radiologists
M. Francone, Rome/IT
Update on the EU Safe Hearts plan
TBA
The EU Safe Hearts plan: where does imaging fit in?
R. Salgado, Antwerp/BE
From diagnosis to prevention in Europe
R. Vliegenthart, Groningen/NL
12:00-12:10 Break
12:10-12:55 Industry Symposium
12:55-13:20 Break
13:20-14:35
Update on ischemia imaging (All Levels)
Guidelines on ischemia imaging in CAD management
R. Nijveldt, Nijmegen/NL
Current role of FFR-CT and CT perfusion
J. Weir-McCall, London/UK
Update on myocardial perfusion MRI
G. Bastarrika, Pamplona/ES
MRI to assess coronary vascular (dys)function
M. Friedrich, Montreal/CA
Q&A
14:35-14:40 Break
14:40-15:05 Industry Slot
15:05-15:35 Break
15:35-17:05
ESCR meets other imaging societies (All Levels)
Radiographers: role in cardiac imaging
Towards high-value, sustainable cardiac imaging
Updates on cardiac CT/MRI in European guidelines
MRI trials with impact on clinical routine
CT trials with clinical diagnostic impact
Role of PET/SPECT in cardiac diagnosis and management
Q&A
17:10-18:10
Interactive Session
Room 2
08:00-09:00
Scientific Session 1
09:00-09:05 Break
09:05-10:05
Scientific Session 2
10:05-13:20 Break
13:20-14:35
Imaging in cardio-oncology: Staying on top of treatment strategies (Advanced)
Imaging cardiac effects of non-immunotherapy systemic cancer therapies
TBA
Cardiac MRI in cancer immunotherapy: Are biopsies outdated?
J. Luetkens, Bonn/DE
Imaging of radiation‐induced coronary artery disease
E. Mousseaux, Paris/FR
Role of nuclear imaging in cardio-oncology
TBA
Q&A
14:35-15:35 Break
15:35-17:05
Basics of cardiac CT and MRI: Technical details explained (Basic)
MRI for tissue characterization
M. Hrabak Paar, Zagreb/HR
Contrast media injection protocols for EID-CT and PC-CT
C. Mihl, Maastricht/NL
Stress MRI perfusion – Pearls and pitfalls
S. Ley, Munich/DE
Stress perfusion CT – Static and dynamic
T. Emrich, Mainz/DE
4D flow MRI – When and how
J. Westenberg, Leiden/NL
Q&A
Friday, October 23, 2026
Room 1
CT at initial presentation in the ED: Can we exclude CAD?
R. Salgado, Antwerp/BE
MRI: Is it MINOCA/Takotsubo/myocarditis…?
M. Pirnat, Maribor/SI
Imaging in OHCA: How and why?
B.K. Velthuis, Utrecht/NL
Q&A
TBA
Coronary calcium evaluation on chest CT?
ESTI/ESCR consensus on imaging pulmonary hypertension
Q&A
J. Shambrook, Southampton/UK
Risk stratification and follow-up in cardiomyopathies
B. Wintersperger, Toronto/CA
Pediatric cardiomyopathies
P. Agarwal, Minneapolis/US
Diving into hypertrophic phenotypes
C. Gkizas, Lille/FR
Arrhythmogenic cardiomyopathy: A moving target
L. Natale, Rome/IT
Q&A
M. Dewey, Cambridge/UK
Stent assessment: Current status
H. Alkadhi, Zurich/CH
Cardiac fat measures: Ready for implementation?
P. Maurovich-Horvat, Budapest/HU
How does PCCT change coronary CTA beyond stenosis?
S. Boccalini, Lyon/FR
Q&A
R. Salgado, Antwerp/BE
Free breathing MRI – Uncooperative patients/young children
G. Muscogiuri, Bergamo/IT
Towards non-contrast cardiac MRI
M. Friedrich, Montreal/CA
Imaging in presence of pacemaker/ICD
J. Bremerich, Basel/CH
Rapid, undersampled MRI
A. Chiribiri, London/UK
Q&A
Room 2
08:00-09:00
Scientific Session 3
09:00-09:05 Break
09:05-10:05
Scientific Session 4
10:05-10:35 Break
10:35-12:05
Imaging for cardiovascular intervention planning (All Levels)
Workup for mitral valve/LAA interventions
TBA
MRI guided interventions: Realtime imaging fusion
M. Guglielmo, Utrecht/NL
Workup for ablation of arrhythmias
TBA
Workup for TAVI
C. Celeng, Utrecht/NL
CCTA/CT-FFR to guide coronary intervention planning?
F. Catapano, Milan/IT
Q&A
12:05-14:15 Break
14:15-15:30
Connecting disciplines: The radiologist connected to… (All Levels)
The pulmonary oncologist (cardiac invading tumors)
G. Tremamunno, Rome/IT
The cardiogeneticist (genetic CMP)
A. Hirsch, Rotterdam/NL
The infectious disease specialist (inflammation/endocarditis)
J. Broncano, Cordoba/ES
The neurologist (cardioembolic stroke)
TBA
Q&A
15:30-16:30 Break
16:30-18:00
How to read congenital heart disease imaging: Case-based (Advanced)
Sequential segmental approach in congenital heart disease
TBA
Grown ups with (incidental) CHD
A. Spijkerboer, Amsterdam/NL
Tetralogy of Fallot
A. Secinaro, Rome/IT
Shunts: ASD, VSD, PAPVR…
TBA
Transposition of the great arteries
T. Semple
Q&A
Saturday, October 24, 2026
Room 1
A. Hirsch, Rotterdam/NL
Updates in echocardiography for valvular imaging
K. Sienkiewicz, Gdansk/PL
Valvular imaging: 4D-flow MRI and beyond
TBA
Q&A
M. Williams, Edinburgh/UK
Spectral CT imaging: When is it helpful?
F. Pontana, Lille/FR
Standardization of CT reporting: How to – role for AI?
TBA
Q&A
Imaging of post-procedural complications: Case-based (All Levels)
TBA
Imaging after treatment of thoracic aorta
C. Loewe, Vienna/AT
Imaging after cardiac transplantation/LVAD
R. Budde, Rotterdam/NL
Imaging after arrhythmia ablation
M. Eberhard, Zurich/CH
Post-valvular intervention imaging
N. Fink, Munich/DE
Q&A
Role of MRI in heart failure guidelines
M. Francone, Milan/IT
MRI tissue characteristics in ischemic cardiomyopathy
MRI tissue characteristics in non-ischemic cardiomyopathies
A. Palmisano, Milan/IT
MRI: Role in myocarditis
M. Gutberlet, Leipzig/DE
Strain MRI: When, how, and why?
R. Manka, Zurich/CH
Q&A
15:25-15:30 Break
Closing Ceremony
Room 2
N. Lama, Athens/GR
MRI: Signal artifacts
R. Holtackers, Maastricht/NL
CT: Motion, trigger, stent and device artifacts
M. Dijkshoorn, Rotterdam/NL
Q&A
TBA
Pearls in imaging for diagnosis of acute aortic syndrome
D. Suchá, Utrecht/NL
Triple rule out CT: When to consider?
TBA
Q&A
TBA
Vasculitis – small, medium and large vessels
TBA
The heart in auto-immune and connective tissue diseases
TBA
Update on MR/CT imaging of amyloidosis
D. Beitzke, Vienna/AT
The great mimicker: Sarcoidosis
M. Hol, Utrecht/NL
Q&A